Related Experiment Videos
Smoking cessation interventions in cardiovascular patients
L C W Wiggers1, E M A Smets, J C J M de Haes
1Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
Summary
Evidence for smoking cessation interventions in cardiovascular patients is limited. Current strategies show minimal effectiveness, highlighting the need for further research into successful methods for this population.
Area of Science:
- Cardiology
- Public Health
- Addiction Medicine
Background:
- Cardiovascular diseases remain a leading cause of mortality globally.
- Smoking is a primary modifiable risk factor for cardiovascular disease.
- Effective smoking cessation strategies are crucial for secondary prevention in cardiac patients.
Purpose of the Study:
- To systematically review the existing evidence on the efficacy of smoking cessation interventions.
- To evaluate the effectiveness of various interventions in cardiovascular patient populations.
- To identify gaps in current research and guide future studies.
Main Methods:
- Systematic review of twelve Cochrane reviews focusing on secondary prevention.
- Inclusion of studies involving smokers diagnosed with symptomatic cardiovascular disease.
- Calculation of Absolute Risk Reduction to quantify intervention effectiveness.
Main Results:
- Only twelve studies met the eligibility criteria for smoking cessation interventions in cardiovascular patients.
- Five studies reported statistically significant results.
- Nicotine replacement therapy, pharmacological aids, self-help materials, and various counseling methods showed no significant effectiveness.
- Limited evidence supports the efficacy of physician's advice and nurse-delivered interventions.
Conclusions:
- Research on smoking cessation interventions for cardiovascular patients is notably scarce.
- The effectiveness of current strategies in this population is very limited.
- The underlying reasons for the low success rates of smoking cessation interventions remain undetermined.
- Further investigation is essential to develop and validate effective cessation strategies for individuals with cardiovascular diseases.